May 13, 2021
Business News

Adamas to Present at Upcoming Healthcare Conferences


EMERYVILLE, Calif.–()–Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced that Neil F. McFarlane, Chief Executive Officer, is scheduled to present at the following investor conferences:

  • 10th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 24 at 1:40 p.m. ET (10:40 a.m. PT)
  • Cowen 41st Annual Healthcare Conference on Tuesday, March 2 at 2:50 p.m. ET (11:50 a.m. PT)
  • H.C. Wainwright Global Life Sciences Conference. Prerecorded presentation available starting on Tuesday, March 9 at 7:30 a.m. ET (4:30 a.m. PT)

The webcasts will be accessible…



Click here to view the original article.

Related Posts

You might also like ...

Industrial Companies Slow to React to Rising Demand for Digital Sales, Accenture Report Finds
NICE Reports 32% Growth in Cloud Revenue for the First Quarter of 2021
Teledyne CML Composites Makes Significant Investment in Thermoplastic Processing Capability in Conjunction with the National Composites Centre